MCHP:NASDAQMicrochip Technology Incorporated Analysis
Data as of 2026-09-01 - not real-time
$71.16
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $71.16, Microchip Technology Incorporated shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it lost 14.7%. Relative strength is 37.9 — approaching oversold — and the MACD signal is bearish. Recent trading has carved out support near $70.45 and resistance around $85.97.
The shares look fair, trading on 104.6 times earnings above a sector average of 35.3. The average analyst target implies 52.7% above today's level. Revenue is growing at 38.0% on a 9.3% profit margin. The 2.48% dividend yield looks stretched against payout coverage.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 60.7%, a beta of 2.14 and a maximum drawdown of 30.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
The shares look fair, trading on 104.6 times earnings above a sector average of 35.3. The average analyst target implies 52.7% above today's level. Revenue is growing at 38.0% on a 9.3% profit margin. The 2.48% dividend yield looks stretched against payout coverage.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 60.7%, a beta of 2.14 and a maximum drawdown of 30.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top Market Events
Microchip Technology Signs Definitive Agreement To Acquire Hailo.Analog chipmaker Microchip Technology NASDAQ:MCHP reported Q2 CY2026 results , with sales up 38% year on year to $1.CHANDLER, Ariz., Aug. 06, 2026 GLOBE NEWSWIRE -- NASDAQ: MCHP – Microchip Technology Incorporated, a leading provider...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 77.08
- MACD momentum is negative
- 30-day price change of -14.7%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 104.6 versus sector average of 35.3
- Dividend yield of 2.48% looks stretched against payout coverage
- Trading below the 200-day average of 77.08
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 104.6 versus sector average of 35.3
- Dividend yield of 2.48% looks stretched against payout coverage
- Analyst targets imply +52.7% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth38.00%
Profit Margin9.34%
P/E Ratio104.6
ROE7.19%
ROA3.54%
Debt/Equity83.69
P/B Ratio6.0
Op. Cash Flow$1.2B
Free Cash Flow$1.4B
Industry P/E35.3
Technical Analysis
TrendNeutral
RSI37.9
Support$70.45
Resistance$85.97
MA 20$76.89
MA 50$81.06
MA 200$77.08
MACDBearish
VolumeDecreasing
Fear & Greed Index92.84
Valuation
Fair Value$77.81
Target Price$108.64
Upside/Downside52.67%
GradeFair
TypeGrowth
Dividend Yield2.48%
Risk Assessment
Beta2.14
Volatility60.69%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.